Low ALK FISH positive metastatic non-small cell lung cancer (NSCLC) patients have shorter progression-free survival after treatment with ALK inhibitors

Gokce A. Toruner, Zhenya Tang, Guilin Tang, L. Jeffrey Medeiros, Shimin Hu

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Fingerprint

Dive into the research topics of 'Low ALK FISH positive metastatic non-small cell lung cancer (NSCLC) patients have shorter progression-free survival after treatment with ALK inhibitors'. Together they form a unique fingerprint.

Medicine & Life Sciences